• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Perfood and Dermanostic Develop Digital Therapy for Psoriasis

Share:

April 29, 2021

German provider of nutritional therapies Perfood and telemedicine provider of dermatology, dermanostic have partnered up to develop digital therapy for the skin condition, psoriasis.

Perfood and dermanostic rely on an online process that links AI-powered skin diagnostics with a personalized low-glycemic dietary intervention using Perfood’s patent-pending Nutrilytics technology.

Through this process, patients are accompanied contact-free from the first assessment by dermanostic through to an intervention with the Perfood digital therapy and continuous monitoring of the disease progression.

Perfood’s technology uses blood glucose monitoring to determine personalized nutritional recommendations that are combined with digital therapy approaches which aim to reduce the symptoms of psoriasis.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • NTT Data Services to Acquire NETE, Expanding Digital Transformation Capabilities in the Federal Healthcare SectorNTT Data Services to Acquire NETE, Expanding Digital Transformation Capabilities in the Federal Healthcare Sector
  • Predictive Oncology Completes Acquisition of Quantitative MedicineAcquisition Focused on Accelerating Commercialization of AI-driven Drug Discovery and DevelopmentPredictive Oncology Completes Acquisition of Quantitative MedicineAcquisition Focused on Accelerating Commercialization of AI-driven Drug Discovery and Development
  • Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19
  • Merck Delays Acceleron Deal Amidst Continuing Stakeholder CriticismMerck Delays Acceleron Deal Amidst Continuing Stakeholder Criticism
  • Cerner Technology to Support COVID-19 Testing for HBCUs NationwideCerner Technology to Support COVID-19 Testing for HBCUs Nationwide
  • LIFE SCIENCES SOFTWARE MARKET TO GAIN SUBSTANTIAL TRACTION THROUGH 2026LIFE SCIENCES SOFTWARE MARKET TO GAIN SUBSTANTIAL TRACTION THROUGH 2026
  • MIT’s COVID-19 App Uses Smartphones’ Bluetooth to Anonymously Spot Disease ContactsMIT’s COVID-19 App Uses Smartphones’ Bluetooth to Anonymously Spot Disease Contacts
  • CloudCath Announces $12 Million Series A Financing for Technology Enabling Remote, Real-Time Complication Monitoring for At-Home DialysisCloudCath Announces $12 Million Series A Financing for Technology Enabling Remote, Real-Time Complication Monitoring for At-Home Dialysis

Trending This Week

  • New tools and acquisitions from OptumRx, ScionHealth.
  • In the wake of Dobbs, women’s health is ‘Ripe for investment’
  • Market Skeptical Following Sen. Warren’s Antitrust Allegations
  • Rogers, Shaw tick lower amid a report that Industry Minister in no hurry to Ok deal
  • ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, furthering its Ambition to Become the Global Leader in Regenerative Therapies
  • LGM Pharma Acquires Pharmaceutical Development and Manufacturing Unit of Nexgen Pharma

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications